Effects of Laquinimod on Standard Oral Contraceptives

Study Title

A Phase I Study in Young Healthy Women to Investigate the Effects of Laquinimod on Standard Oral Contraceptive When Both Treatments Are Given Together

Teva Identifier

TV5600-PK-10017 | 2013-005356-14

ClinicalTrials.gov Identifier

NCT02085863

Study Status

Completed

Trial Condition(s)

Pharmacokinetics | Pharmacodynamics

Interventions

Drug: laquinimod | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
female icon for clinical trials

Key Participation Requirements

Gender

Female

Age Range

18 Years to 40 Years

Trial Duration

02/01/2014 - 11/01/2014

Phase

Phase 1

Study Type

Interventional